ADVERTISEMENT
News
Class II Recall Active for Combigan
04/04/2019
Recalled are 5-mL bottles of Combigan (NDC 0023-9211-05) from lot 99946 (Exp. 1/16/21). Bottles affected by the recall were distributed in Tennessee.
Allergan Sales voluntarily initiated the recall March 19, 2019. On March 22, 2019, the FDA designated it Class II. The classification suggests use of the product could cause temporary or medically reversible adverse health consequences or a remote possibility of serious harm.
Combigan is a prescription ophthalmic solution used to reduce pressure in the eye from glaucoma or ocular hypertension.
—Jolynn Tumolo
Stay Informed & Sign Up Today
Pharmacy Learning Network Newsletter
